These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2571303)

  • 1. Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition.
    Rettig R; Geist R; Sauer U; Rohmeiss P; Unger T
    Am J Physiol; 1989 Sep; 257(3 Pt 2):R588-94. PubMed ID: 2571303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization to pressor effects by repeated central injections of vasopressin in conscious rats.
    Lebrun CJ; Rohmeiss P; Demmert G; Unger T
    Brain Res; 1989 Dec; 505(1):39-43. PubMed ID: 2611677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential actions of neuronal and hormonal vasopressin on blood pressure and baroreceptor reflex sensitivity in rats.
    Unger T; Rohmeiss P; Demmert G; Luft FC; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S81-6. PubMed ID: 2434779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
    Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E
    Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central effects of angiotensin II in conscious hamsters: drinking, pressor response, and release of vasopressin.
    Rettig R; Gerstberger R; Meyer JU; Intaglietta M; Printz MP
    J Comp Physiol B; 1989; 158(6):703-9. PubMed ID: 2715457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism.
    Thornhill J; Gregor L; Pittman Q
    Regul Pept; 1990 Oct; 31(1):1-10. PubMed ID: 1980152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of centrally administered ET-1-induced increases in systemic arterial pressure and AVP secretion.
    Rossi NF; O'Leary DS; Chen H
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E126-32. PubMed ID: 9038861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central effects of prostaglandin E2 on blood pressure and plasma renin activity in rats. Role of the sympathoadrenal system and vasopressin.
    Okuno T; Lindheimer MD; Oparil S
    Hypertension; 1982; 4(6):809-16. PubMed ID: 6292084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release.
    Janiak P; Kasson BG; Brody MJ
    Hypertension; 1989 Jun; 13(6 Pt 2):935-40. PubMed ID: 2737730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of opioids and vasopressin in central action of angiotensin II in conscious rabbits.
    Fukuhara M; Matsumura K; Abe I; Fujishima M
    Hypertens Res; 1998 Jun; 21(2):89-95. PubMed ID: 9661804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
    Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
    J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D; Gaffori O; Van Ree JM; De Jong W
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of vasopressin in the cardiovascular effects of intracerebroventricularly administered alpha 1-adrenoceptor agonists in the conscious rat.
    Hiwatari M; Johnston CI
    J Hypertens; 1985 Dec; 3(6):613-20. PubMed ID: 2868056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
    Poulin P; Komulainen A; Takahashi Y; Pittman QJ
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of autonomic nervous system adjustments to heat stress by central ANG II receptor antagonism.
    Kregel KC; Stauss H; Unger T
    Am J Physiol; 1994 Jun; 266(6 Pt 2):R1985-91. PubMed ID: 8024055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central effects of substance P and somatostatin in conscious, streptozotocin-treated rats.
    Tomlinson KC; Gardiner SM; Bennett T
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R405-10. PubMed ID: 1697738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic activation following central vasopressin receptor stimulation in conscious rats.
    Unger T; Rohmeiss P; Becker H; Ganten D; Lang RE; Petty M
    J Hypertens Suppl; 1984 Dec; 2(3):S25-7. PubMed ID: 6100738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of injections of vasopressin into the nucleus tractus solitarius in conscious rats.
    King KA; Pang CC
    Br J Pharmacol; 1987 Mar; 90(3):531-6. PubMed ID: 3567458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.